Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical University, Saitama, Japan.
Department of Endoscopy and Endoscopic Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Gastrointest Endosc. 2015 Oct;82(4):697-707.e1. doi: 10.1016/j.gie.2015.03.1978. Epub 2015 May 12.
Endoscopic self-expandable metal stent placement has been used as an alternative to surgery for malignant colorectal obstruction; however, factors affecting its clinical outcome are unclear.
To clarify the short-term safety and efficacy of endoscopic self-expandable metal stent placement for malignant colorectal obstruction and to identify factors associated with its clinical and technical failure.
Prospective clinical cohort study.
Fourteen academic centers and 32 community hospitals.
A total of 513 consecutive patients with malignant colorectal obstruction.
Endoscopic self-expandable metal stent placement, sharing of stent placement methods among participating facilities.
The primary endpoint was clinical success, defined as symptom and radiological finding resolution within 24 hours. Secondary endpoints were technical success and adverse events. The follow-up period was 7 days.
The clinical and technical success rates were 95.5% and 97.9%, respectively. Major adverse events included perforation (2.1%), stent migration (1.0%), and stent occlusion (0.8%). The main causes of perforation were the procedure itself (0.8%) and comorbidities (obstructive colitis and impending perforation) not apparent before stent placement (0.6%). Extrinsic tumor origin was independently associated with the clinical failure after stent placement (odds ratio 4.23; 95% confidence interval, 1.21-14.79; P = .02). Stricture marking trended toward a negative association with technical failure (P = .09).
Noncomparative study.
Strict inclusion criteria and stricture marking may improve the technical and clinical success of stent placement.
内镜下自膨式金属支架置入术已被用作治疗恶性结直肠梗阻的手术替代方法;然而,影响其临床效果的因素尚不清楚。
阐明内镜下自膨式金属支架置入术治疗恶性结直肠梗阻的短期安全性和有效性,并确定与临床和技术失败相关的因素。
前瞻性临床队列研究。
14 个学术中心和 32 个社区医院。
共 513 例连续的恶性结直肠梗阻患者。
内镜下自膨式金属支架置入术,参与机构共享支架置入方法。
主要终点是临床成功,定义为 24 小时内症状和影像学发现缓解。次要终点是技术成功和不良事件。随访期为 7 天。
临床和技术成功率分别为 95.5%和 97.9%。主要不良事件包括穿孔(2.1%)、支架移位(1.0%)和支架阻塞(0.8%)。穿孔的主要原因是手术本身(0.8%)和支架置入前不明显的并存疾病(梗阻性结肠炎和即将穿孔)(0.6%)。肿瘤的外在起源与支架置入后的临床失败独立相关(比值比 4.23;95%置信区间,1.21-14.79;P =.02)。狭窄标记与技术失败呈负相关趋势(P =.09)。
非比较性研究。
严格的纳入标准和狭窄标记可能会提高支架置入的技术和临床成功率。